Abstract:What's New? Patients with non‐muscle‐invasive bladder cancer (NMIBC) have a high risk of recurrence, and although smoking is considered the most important modifiable risk factor for bladder cancer, it is not clear from the data how smoking affects the risk of recurrence and progression of NMIBC. Here, the authors analyzed data from the prospective, multi‐center UroLife study, which collected data on a variety of factors related to smoking habits. Heavier smoking was associated with higher recurrence risk, especially among patients treated with Bacillus Calmette‐Guerin immunotherapy. However, they found no associations with smoking status, duration, or time since cessation. Studies on the relationship of cigarette smoking with the risks of recurrence and progression of non‐muscle‐invasive bladder cancer (NMIBC) are inconsistent and prospective data are scarce. Therefore, we aimed to assess the association of smoking behavior with risks of NMIBC recurrence and progression. We used data of the prospective multi‐center cohort study UroLife, including 1495 patients with NMIBC who reported information on smoking at 6 weeks post‐diagnosis (baseline; reflecting present and pre‐diagnosis). This included smoking status (also based on reporting 3 months post‐diagnosis), intensity, duration, pack years, and time since smoking cessation, if applicable. Hazard ratios and 95% confidence intervals (CIs) for risks of first recurrence, multiple recurrences, and progression were computed using multivariable proportional hazards regression models. During a total median follow‐up period of 4.6 years, 517 patients developed ≥1 recurrence and 163 had progression. Higher versus lowest categories of smoking intensities and pack years up to baseline were significantly associated with a higher risk of first recurrence. No significant linear associations were found, except for smoking intensity among BCG‐treated patients (per 10 cigarettes/day increase: HR 1.23, 95%CI 1.02, 1.48). No associations for smoking status, duration, and time since cessation were observed. Analyses of multiple recurrence risk showed comparable results. Regarding progression risk, no consistent associations were found. In conclusion, heavier smoking was associated with higher recurrence risk, particularly among BCG‐treated patients. This may be attributable to persistent damage through its carcinogenic compounds. Given the mixed results across different exposures, the effect of smoking behavior on NMIBC prognosis remains unclear.

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease

Association Between Smoking and Molecular Subtypes of Colorectal Cancer

[Smoking and digestive tract: a complex relationship. Part 1: Inflammatory bowel disease and cigarette smoking]

Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.

Cigarette Smoking and the Risk of Colorectal Cancer: A Meta-analysis of Prospective Cohort Studies

P1180 Smoking behaviour and changes after diagnosis in patients with Crohn's disease in a tertiary referral hospital: A retrospective explorative study

Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype

Associations of smoking with early- and late-onset colorectal cancer

Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction

Alcohol consumption and smoking history at time of diagnosis, and risk of colorectal cancer recurrence and mortality: Results from the ColoCare Study

Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease

A Pooled Analysis of Smoking and Colorectal Cancer: Timing of Exposure and Interactions with Environmental Factors

Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study among Half a Million Adults in UK Biobank

Smoking status at diagnosis and subsequent smoking cessation: associations with corticosteroid use and intestinal resection in crohn's disease

Interaction of Smoking and Metabolic Syndrome in Increasing the Recurrence Risk of Colorectal Cancer in a Chinese Male Cohort: a Retrospective Study

Smoking behavior and the risks of tumor recurrence and progression in patients with non‐muscle‐invasive bladder cancer

Correlation Between Smoking History and Molecular Pathways in Sporadic Colorectal Cancer: a Meta-Analysis.

Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response

Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease